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Abstract
High plasma lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for atherosclerotic diseases. To date, no effective inter-
vention strategies on reducing Lp(a) concentrations have been reported. The aim of the study was to evaluate the possible modulation of two
polymorphisms of LPA gene (LPA 93C>T and LPA 121G>A) and nutritional habits on Lp(a) concentrations. We studied 647 healthy Italian
subjects (260 M; 387 F) with a median age of 48 years (range: 19–78) enrolled in an epidemiological study conducted in Florence, Italy. A
linear regression analysis showed a significant negative influence of fish intake (β = −0.174 ± 0.084; p = 0.04) on Lp(a) concentrations, after
adjustment for smoking habit, C-reactive protein serum concentrations, dietary habits and LDL-cholesterol concentrations. With regard to
LPA polymorphisms, LPA 93C>T polymorphism resulted to significantly affect Lp(a) circulating concentrations in a dose-dependent manner,
with lower concentrations shown by subjects carrying the T rare allele, whereas no significant influence of LPA 121G>A polymorphism on
Lp(a) concentrations was observed. Moreover, by analyzing the possible interplay between LPA 93C>T and dietary fish intake, a significant
interaction between these two determinants in lowering Lp(a) concentrations was reported. In addition, lower Lp(a) concentrations were
observed in subjects carrying the T allele of the LPA 93C>T polymorphism and consuming a high intake of fish with respect to those being
in the highest tertile of fish consumption but homozygotes for the common allele of the polymorphism. In conclusion, this study reported a
significant interaction of daily fish intake and LPA 93C>T polymorphism in decreasing Lp(a) concentrations.
© 2007 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Lipoprotein (a) [Lp(a)] is a plasma particle composed
of a LDL particle and a highly glycosylated apolipoprotein,
apo(a), disulfide linked to the apo B-100 of the LDL [1]. As
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a result of its structural similarity to LDL, Lp(a) has athero-
genic properties [2]. In addition, Lp(a) has antifibrinolytic
and thrombosis-promoting properties that arise from the
structural similarity of apo(a) to plasminogen [3]. Over the
last years, a large number of clinical studies reported evi-
dence for an association between high Lp(a) concentrations
and an increased risk for atherosclerotic diseases, including
coronary heart disease, and stroke [4–9]. However, despite
much progress in the knowledge of the atherogenic role of
Lp(a), no effective therapeutic strategies on lowering Lp(a)
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concentrations have been found [10]. Moreover, dietary
habits seem not to significantly affect Lp(a) circulating con-
centrations [11]. Recently, some intervention studies based
on the effect of fish oil rich in n-3 polyunsaturated fatty acids
(PUFA) on Lp(a) concentrations have been conducted, but no
clear indications have been obtained [12–15]. Lp(a) concen-
trations are thought to be strongly under genetic control at the
concentration of biosynthesis of the apo(a) protein, which is
encoded by the LPA locus, so allelic differences at LPA are
responsible for the variations in Lp(a) phenotype [16].
Data from in vitro and in vivo studies demonstrated that
polymorphisms in the 5′-flanking region of the LPA gene
affect the efficiency of its expression, so contributing to the
regulation of Lp(a) concentrations, [17,18] and influence the
variation of the promoter transcription activity in HepG2 cells
[19]. Suzuki et al. by exploring the mechanisms of the genetic
control of Lp(a) concentrations, demonstrated a relationship
between polymorphisms in the LPA 5′-flanking region and
different Lp(a) concentrations [17]. In particular, the C→T
transition at position +93 of the transcription start site creates
a new translation start codon, leading to a negative regulation
in the protein synthesis, while the change of G to A, at position
+121, determine a positive regulation of gene expression [17].
Furthermore, a role for LPA 93C>T polymorphism in
affecting both the promoter activity [19] and Lp(a) concen-
trations in Africans, but not in Caucasians, was demonstrated
[18]. It has been recently demonstrated, indeed, that LPA
93C>T, but not LPA 121G>A polymorphism influences
Lp(a) concentrations among a population from Czech
Republic [20].
To the best of our knowledge, no study which investigated
both genetic and nutritional determinants of Lp(a) concentra-
tions among a clinically healthy population was performed.
Therefore, aims of the study were: (1) to investigate the
role of nutritional habits on modulating Lp(a) concentrations,
(2) to evaluate the weight of the LPA locus in influencing
Lp(a) concentrations by analysing the 93C>T and 121G>A
polymorphisms at LPA locus, (3) to establish the possible
interplay existing between LPA locus and dietary habits in
modulating Lp(a) concentrations.
2. Methods
2.1. Subjects
The study population includes subjects enrolled in an
epidemiologic study “Alimentazione per la Salute e la Pre-
venzione di Malattia”, which was conducted in Florence,
Italy with the aim of evaluating dietary and lifestyle habits
of a middle-aged clinically healthy population. Details of the
study are described in details elsewhere [21]. Briefly, from
January 2002 to January 2004, 932 healthy subjects randomly
drawn from the population registers of Florence, Italy, which
are updated regularly, were enrolled in the study. The study
was designed to enrol 1000 clinically healthy subjects. How-
ever, at the time of enrolment 68 subjects were excluded from
the study since they refused to participate or reported low
energy intake/basal metabolic rate (<1.14), as classified by
using Goldberg cutoff. Overall, the participation rate was over
80% and the final study population was still representative of
the whole population of the district (about 10%). A physical
examination, anthropometric and blood pressure measure-
ments, laboratory tests, and dietary survey were conducted
by physicians and dieticians by using standardized protocols.
Body mass index (BMI) was calculated as weight
(kg)/height (m2). Three consecutive measures of blood pres-
sure were taken after the subject had been resting for 10 min,
and the average of the last two were used to calculate systolic
and diastolic blood pressure. The subjects were classified as
having hypertension according to the guidelines of European
society of hypertension/European society of cardiology [22]
or if they reported taking antihypertensive medications, as
verified by the interviewer. Diabetic subjects were defined
in line with the American diabetes association [23] or on
the basis of self-report data (if confirmed by medication
or chart review). Dyslipidemia and the metabolic syndrome
were defined by following the criteria of the ATP III expert
panel of the US National cholesterol education program [24].
All subjects gave informed consent and the study was
approved by the local ethic committee.
Trained dieticians collected data in order to assess the
habitual consumption of 109 food items, by performing a
food-frequency questionnaire previously validated in Italy,
and updated in 2003 [25]. For each specific food item a
commonly used portion size was specified and subjects were
asked how often they had consumed that unit (never, daily,
weekly, monthly) on average during the past year. Emphasis
was laid to ensure that the answers were related to a year-
long dietary pattern and not to last few months, especially in
terms of seasonal changes of diet. Portion sizes were shown
in color photographs and indicated by the letters A (small),
B (medium), C (large), D (very large). All data were then
converted into nutrient daily intake using a specific software
(InDali®) and a computerized database derived from the Ital-
ian standard food composition tables. A reduction between
33 and 66% of the indicated portions has been applied for
seasonal foods. Lp(a) circulating concentrations and LPA
polymorphisms were obtained in 647 subjects (260 M; 387 F)
with a median age of 48 years (range: 19–78).
All subjects gave informed consent and the study was
approved by the local ethical committee.
2.2. Determination of Lp(a) and CRP
Venous blood samples were taken, in the morning, after
an overnight fasting. To determine Lp(a) and C-reactive
protein (CRP) concentrations, venous blood was put in
tubes without anticoagulant, centrifuged at room temper-
ature (2000 g× 15 min) and stored at −80 ◦C until assay.
Lp(a) concentrations were determined by an ELISA method
(Mercodia Apo(a), Mercodia AB, Uppsala, Sweden). High
Author's personal copy
F. Sofi et al. / Atherosclerosis 195 (2007) e147–e154 e149
sensitivity CRP was assessed by a BNII nephelometer (Dade
Behring, Marburg, Germany).
2.3. Determination of LPA polymorphisms
Genomic DNA was extracted from peripheral blood leuko-
cytes by using the Flexigene DNA kit (Qiagen, GmbH,
Germany). LPA 93C>T and 121G>A polymorphisms were
evaluated through an electronic microchip (NanoChip®
molecular biology workstation; nanogen, San Diego, CA,
USA) as otherwise described [26,27].
3. Statistical analysis
Statistical analyses were performed using the SPSS soft-
ware (Chicago, IL, USA) for Windows (Version 11.5).
Variables were reported as mean and S.D. or median and
range, as appropriate. To evaluate the influence of nutritional
as well as demographic and anthropometric biomarkers on
Lp(a) concentrations we divided our study population into
tertiles of age (first tertile: <40 years; second tertile: 40–54
years; third tertile: >55 years) and of Lp(a) distribution (first
tertile: <104.8 mg/L; second tertile: 104.8–177.6 mg/L; third
tertile: >177.6 mg/L). Kruskall–Wallis test was performed
to investigate for comparisons among groups. Chi-square
test was used to test for proportions and for deviation
of genotype distribution of LPA polymorphisms from the
Hardy-Weinberg equilibrium. The interaction hypotheses
between Lp(a), fish intake and age tertiles in the different
genotypes were ascertained by the likelihood ratio testing.
Because Lp(a) distribution was right-skewed, values were
log-transformed in regression analyses and back transformed
for data presentation. To evaluate the influence of fish intake
on Lp(a) concentrations, a linear regression analysis after
adjustment for age, gender, smoking habit, CRP concen-
trations, total energy intake, alcohol and lipid intake as
well as LDL-cholesterol concentrations, was performed and
results were expressed as regression coefficient (β) ± SE. In
addition, general linear models with polynomial contrasts
for linear trend of distribution were used to analyse Lp(a)
concentrations according to tertiles of fish intake (first ter-
tile: <23 g/day; second tertile: 23.1–45 g/day; third tertile:
>45 g/day) and different genotypes of LPA 93C>T polymor-
phism and values were expressed as geometric mean and
95% confidence interval. LPA polymorphisms were evalu-
ated under a dominant genetic model. The dominant genetic
model compares individuals with one or more polymorphic
alleles with a baseline group with no polymorphic alleles (e.g.
LPA 93CT+TT versus 93CC). All the general linear mod-
els were performed after adjustment for age, gender, total
energy intake, smoking habit, CRP concentrations, lipid and
alcohol intake, and LDL-cholesterol concentrations. Finally,
a logistic regression analysis, in order to evaluate the asso-
ciation between fish intake and concentrations of Lp(a) in
the third tertile, after adjustment for age, gender, total energy
intake, smoking habit, CRP concentrations, lipid and alcohol
intake, and LDL-cholesterol concentrations, was performed.
Odds ratios and 95% confidence intervals are presented. A
p-value less than 0.05 was considered to indicate statistical
significance.
4. Results
4.1. Nutritional determinants of Lp(a) concentrations
Median value of Lp(a) in our study population was 107
with a range of 3–1670 mg/L. Females showed significantly
higher Lp(a) concentrations with respect to males [111
(3–1670) mg/L versus 105 (6–1500) mg/L; p = 0.02]. In par-
ticular, the subgroup of 137 menopausal women reported
significantly (p = 0.006) higher Lp(a) concentrations than
nonmenopausal women [129 (6–1390) mg/L versus 105
(3–1670) mg/L, respectively].
Demographic, anthropometric, laboratory, and nutritional
parameters according to different tertiles of Lp(a) concen-
trations are described in Table 1. Higher LDL-cholesterol
and C-reactive protein levels resulted to be significantly
associated to the highest tertiles of Lp(a) levels, while
no significant association for tryglicerides was observed.
With regard to nutritional habits, a higher fish intake was
reported to be significantly associated with lower Lp(a)
concentrations, whereas no significant association for all
the other nutritional parameters was observed. A linear
regression analysis showed a significant influence of fish
intake on Lp(a) concentrations, after adjustment for other
possible confounders of Lp(a) concentrations, such as age,
gender, smoking habit, CRP concentrations, total energy
intake, lipid and alcohol intake as well as LDL-cholesterol
concentrations (β = −0.174 ± 0.084; p = 0.04).
To evaluate the possible influence of fish intake on Lp(a)
concentrations we divided our study population into ter-
tiles of fish intake, and a significant trend of decrease for
Lp(a) concentrations according to the highest tertiles of fish
consumption was observed (Fig. 1). Moreover, a logistic
regression analysis showed a significant lower risk of hav-
ing Lp(a) concentrations in the highest tertile for subjects
being in the highest tertile of fish intake (OR: 0.54 95%C.I.
0.32–0.89; p = 0.04), after adjustment for age, gender, smok-
ing habit, CRP concentrations, total energy intake, lipid and
alcohol intake, and LDL-cholesterol concentrations.
4.2. LPA polymorphisms and Lp(a) concentrations
Genotype distribution and allele frequencies of LPA
93C>T and LPA 121G>A polymorphisms were in agreement
with those predicted by Hardy-Weinberg equilibrium and
are reported in Table 2. A significant difference in genotype
distribution for LPA 93C>T, but not LPA 121G>A polymor-
phism among tertiles of Lp(a) concentrations, was observed
(p = 0.03 and p = 0.4, respectively).
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Table 1
Demographic, anthropometric and nutritional characteristics according to tertiles of Lp(a) concentrations
Lp(a)
First tertile (<104.8 mg/L) Second tertile (104.8–177.6 mg/L) Third tertile (>177.6 mg/L) p
Age, yearsa 45 (20–74) 50 (19–78) 49 (25–76) 0.02b
Females, n (%) 126 (58.6) 124 (57.4) 135 (62.5) 0.5c
Waist circumference (cm) 85.6 ± 14.4 87.1 ± 14.1 87.1 ± 14 0.5b
BMI (kg/m2) 24.9 ± 4.6 24.8 ± 4.4 25.0 ± 4.3 0.5b
Smoking habit, n (%) 109 (50.7) 122 (56.5) 114 (52.8) 0.5c
Hypertension, n (%) 29 (13.5) 35 (16.2) 28 (12.9) 0.6c
Dyslipidemia, n (%) 25 (11.6) 30 (13.9) 28 (12.9) 0.8c
Diabetes, n (%) 6 (2.8) 8 (3.7) 7 (3.2) 0.9c
Tryglicerides, mg/dL 118.2 ± 101.7 114.5 ± 83.7 118.6 ± 102.7 0.5b
LDL-cholesterol, mg/dL 108.4 ± 34.2 115.5 ± 31.1 120.8 ± 32.3 0.001b
C-reactive protein, mg/L 2.3 ± 1.5 2.4 ± 1.5 2.7 ± 2.4 0.04b
Dietary pattern
Total energy intake (Kcal/day) 2061.1 ± 605.7 2108.5 ± 590.8 2053.7 ± 559.4 0.6b
Protein intake (% Kcal) 17.3 ± 3.5 17.2 ± 2.9 17.0 ± 2.9 0.5b
Carbohydrates (% Kcal) 51.2 ± 7.7 50.7 ± 7.2 51.7 ± 7.1 0.3b
Total fats (% Kcal) 33.9 ± 7.5 33.4 ± 6.6 33.2 ± 6.1 0.7b
SFA (% Kcal) 9.8 ± 2.5 9.6 ± 2.5 9.6 ± 2.5 0.8b
MUFA (% Kcal) 12.7 ± 3.9 12.9 ± 4.1 12.5 ± 3.5 0.9b
PUFA (% Kcal) 3.0 ± 0.9 3.1 ± 1.0 2.9 ± 0.8 0.2b
Fibre (g/day) 21.2 ± 6.1 22.2 ± 7.9 22.2 ± 6.4 0.3b
Cholesterol (mg/day) 195.1 ± 86.1 199 ± 76.1 194.6 ± 92.6 0.3b
Alcohol intake (g/day) 7.5 ± 4.4 8.5 ± 3.9 8.6 ± 3.5 0.3b
Vitamin E (mg/day) 10.4 ± 5 10.5 ± 5 11 ± 5 0.7b
Vitamin C (mg/day) 135 ± 58.2 131.1 ± 52.5 141.9 ± 62 0.7b
Folic acid (mg/day) 310.7 ± 137.3 311.6 ± 129.3 318.6 ± 130.4 0.2b
Vitamin B6 (mg/day) 1.78 ± 0.6 1.78 ± 0.65 1.80 ± 0.62 0.9b
Food groups
Dairy products (g/day) 244.2 ± 157.6 255.9 ± 166.7 254.9 ± 128.4 0.5b
Cereals (g/day) 342.2 ± 186.2 376.9 ± 194.6 385.7 ± 303.2 0.1b
Fish intake (g/day) 38.6 ± 27.8 31.7 ± 21.3 32.7 ± 22.4 0.04b
Meat (g/day) 95.6 ± 75.9 82.1 ± 51.1 91.5 ± 70.9 0.1b
Vegetables (g/day) 132.1 ± 41.8 132.8 ± 42.9 146.1 ± 59.7 0.9b
Nuts (g/day) 12.9 ± 11.2 14.9 ± 13.6 10.3 ± 9.5 0.6b
Fruits (g/day) 84.7 ± 50.6 83.2 ± 47.6 78.5 ± 48.1 0.7b
Legumes (g/day) 37.8 ± 30 41.3 ± 34.7 37.7 ± 31.1 0.7b
Olive oil (g/day) 42 ± 34.3 43.9 ± 32.7 39.9 ± 37.8 0.3b
Values are expressed as mean ± S.D.
BMI, body mass index; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids.
a Median and (range).
b Kruskall–Wallis test.
c Chi-square test.
Table 2
Genotype distributions of LPA polymorphisms in the whole population and according to tertiles of Lp(a)
Genotype
distribution (%)
Allele frequency Study population
(n = 647)
Lp(a) tertiles
First tertile
(<104.8 mg/L)
Second tertile
(104.8–177.6 mg/L)
Third tertile
(>177.6 mg/L)
LPA93CC, n 458 (70.8) 145 (67.4) 146 (67.6) 167 (77.3)
LPA93CT, n 176 (27.2) 66 (30.7) 62 (28.7) 48 (22.2)
LPA93TT, n 13 (2.0) 4 (1.9) 8 (3.7) 1 (0.5)
LPA93T 0.16
LPA121GG, n 524 (81.0) 180 (83.7) 175 (81) 169 (78.2)
LPA121GA, n 120 (18.5) 34 (15.8) 41 (19) 45 (20.8)
LPA121AA, n 3 (0.5) 1 (0.5) – 2 (0.9)
LP121A 0.10
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Fig. 1. Lp(a) concentrations according to tertiles of fish intake. Values are
shown as geometric mean (95% C.I.). General linear model adjusted for age,
gender, smoking habit, CRP concentrations, total energy intake, lipid and
alcohol intake, LDL-cholesterol concentrations.
Moreover, as Lp(a) concentrations among the differ-
ent genotypes of LPA polymorphisms were evaluated, we
observed a statistically significant trend of decrease of Lp(a)
concentrations according to the increasing number of LPA
93T allele, after adjustment for possible confounders (age,
gender, smoking habit, CRP concentrations, total energy
intake, lipid and alcohol intake, as well as LDL-cholesterol
concentrations) (Fig. 2). Conversely, no significant dif-
ferences for Lp(a) concentrations among LPA 121G>A
genotypes were found (p = 0.3).
Since increasing age was significantly related to higher
tertiles of Lp(a) concentrations, we searched for a possible
influence of age and LPA 93C>T polymorphism on Lp(a)
concentrations. At a general linear model, after adjustment
for possible confounding factors we observed that subjects
in the highest tertile of age and carrying the rare 93T allele
had significantly lower Lp(a) concentrations than subjects
belonging to the same tertile of age but homozygotes for
the wild type 93C allele [93CT+TT: 83.8 (46.7–150.2) mg/L
versus 93CC: 193.8 (146.9–255.4) mg/L; p = 0.001].
Fig. 2. Lp(a) concentrations according to LPAC93T polymorphism. Values
are shown as geometric mean (95% C.I.). General linear model adjusted for
age, gender, smoking habit, CRP concentrations, total energy intake, lipid
and alcohol intake, LDL-cholesterol concentrations.
4.3. Relationship between fish intake and LPA 93C>T
polymorphism on Lp(a) concentrations
In order to investigate the possible interplay between fish
intake and LPA polymorphisms in influencing Lp(a) concen-
trations, we evaluated the effect of daily fish consumption on
Lp(a) concentrations among the different genotypes of LPA
93C>T polymorphism. Fish intake was found to significantly
affect Lp(a) concentrations in subjects carrying the 93T
allele (TC+TT genotypes) (β = −0.591 ± 0.167; p = 0.001),
but not in homozygotes for the LPA 93C allele (CC genotype)
(β = 0.038 ± 0.092; p = 0.7), at a linear regression model after
adjustment for age, gender, smoking habit, CRP concen-
trations, total energy intake, lipid and alcohol intake, and
LDL-cholesterol concentrations.
Hence, we investigated Lp(a) concentrations according to
LPA 93C>T polymorphism and tertiles of fish intake, by
observing that a significant interaction between LPA 93T
allele and fish intake in reducing Lp(a) concentrations was
present (Fig. 3). Indeed, significantly lower Lp(a) concen-
trations were observed in subjects carrying at least one LPA
93T allele and being in the third tertile of fish intake (like-
lihood ratio test: p = 0.001), with respect of subjects who
were in the third tertile of fish intake but not carrying the
LPA 93T allele (likelihood ratio test: p = 0.3) (Fig. 3). This
result remained significant even after menopausal women
were excluded from the analysis.
Finally, we conducted a multiple regression analysis to
estimate the risk of having Lp(a) concentrations in the high-
est tertile according to tertiles of fish intake and LPA 93C>T
polymorphism and a significant protection against being in
the third tertile of Lp(a) for subjects consuming a higher
amount of daily fish was observed only when the 93T allele
was present (OR: 0.12; 95%C.I. 0.03–0.46; p = 0.02) after
adjustment for age, gender, smoking habit, CRP concen-
Fig. 3. Lp(a) concentrations according to fish intake and LPAC93T polymor-
phism. Values are expressed as geometric mean (95% confidence interval).
General linear model adjusted for age, gender, smoking habit, CRP con-
centrations, total energy intake, lipid and alcohol intake, LDL-cholesterol
concentrations.
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trations, total energy intake, lipid and alcohol intake, and
LDL-cholesterol concentrations.
5. Discussion
This study observed a significant interaction between
a dietary component, namely fish intake and a genetic
determinant, the LPA 93C>T polymorphism, in modulat-
ing circulating Lp(a) concentrations. Indeed, significantly
lower Lp(a) concentrations in subjects carrying the LPA 93T
allele of the LPA 93C>T polymorphism and who were in
the highest tertile of fish intake, as compared to subjects
who consume a high intake of fish from diet but who carry
the LPA 93C wild-type allele, were observed. To the best
of our knowledge, this is the first report of a gene–diet
interaction in modulating Lp(a) circulating concentrations.
To date, other examples of gene–environment interaction
in modulating circulating lipoproteins, in previous studies,
have been reported, indicating that diet may influence cir-
culating lipoproteins in genetically predisposed individuals
[28,29]. In particular, a diet rich in n-3 PUFA of fish origin has
been shown to determine a beneficial change in lipid profile
only among subjects predisposed for polymorphic variants
of the gene encoding for components of the lipid particles
[29].
A large number of clinical studies, during the last decades,
have provided strong evidence for an association between
high Lp(a) concentrations and increased risk for atheroscle-
rotic diseases [4–9]. However, despite intense scientific
efforts, effective interventions for lowering Lp(a) concentra-
tions in clinical practice are scarce and limited [10]. Lp(a)
concentrations are strongly influenced by genetic factors and
seems not to be influenced by diet, exercise, environmen-
tal conditions and drugs [11]. In our study population we
demonstrated a significant influence of fish intake on Lp(a)
concentrations. This is the first evidence of an influence,
albeit modest, of fish consumption on this cardiovascular
risk marker, in an industrialized population. In 1999, a report
from the Lugalawa study reported that a population of Bantu
fishermen from Tanzania had significantly lower Lp(a) con-
centrations as compared to a genetically similar population
of vegetarians [30]. The authors accounted this difference
of Lp(a) concentrations to the large amount of fish daily
consumed by the fishermen. On the other hand, this study
was conducted in two populations far removed from a west-
ern lifestyle, consuming a high intake of daily fish from
diet, thus probably not fully reflecting the “real world” of
the western diet. Our population study, instead, is a cohort
of subjects living in a Mediterranean region and mostly
consuming a Mediterranean-like diet. With regard to fish
consumption, our population did not report a high mean
value of daily fish intake from diet. Nevertheless, by divid-
ing the study population into tertiles of fish consumption we
observed an inverse association between the highest intake
of fish from diet and Lp(a) circulating concentrations, even
after adjustment for the other dietary variables and for LDL-
cholesterol.
Actually, the mechanisms linking high fish intake and
lower Lp(a) concentrations are not yet well established. How-
ever, some hypotheses can be made. Lp(a) has been reported
to play a role in the inflammatory process, and it has been
evidenced an association between Lp(a) and inflammation
reactants such as interleukin-6 and CRP [31]. Conversely,
n-3 PUFA endow anti-inflammatory properties, so signif-
icantly attenuating inflammatory parameters [32]. Hence,
it may be postulated that a diet rich in n-3 PUFA is able
to modulate Lp(a) concentrations by reducing inflamma-
tory state. Furthermore, it can also be hypothesized that n-3
fatty acids may affect apo(a) metabolism, either by impair-
ing its assembly with LDL or by enhancing its catabolism
[33].
Currently, some intervention studies based on the effect of
fish oil rich in PUFA n-3 on Lp(a) concentrations have been
conducted but they did not report clear indications [12–15].
Some studies resulted in a significant reduction of Lp(a) con-
centrations [12–14], whereas a controlled study did not show
any change in Lp(a) concentrations [15]. These differences
may be related to the different genetic and nutritional back-
ground of the study populations, as well as by the different
therapeutic interventions in terms of duration and dosage,
among these studies.
Another finding of this study is the significant modulation
of Lp(a) concentrations shown by LPA 93C>T polymor-
phism. In our study population we analyzed, together with
Lp(a) circulating concentrations, two polymorphisms of gene
encoding for apo(a), the LPA 93C>T and the LPA 121G>A
polymorphisms. LPA 93C>T polymorphism resulted to sig-
nificantly affect Lp(a) concentrations, as seen by significantly
lower Lp(a) concentrations among subjects carrying T variant
allele as compared to homozygotes for the common vari-
ant. This result is in keeping with data from an experimental
study which demonstrated that nucleotide changes at apo(a)
promoter region, such as LPA 93C>T may contribute to the
variation of its transcription activity, thus influencing Lp(a)
concentrations [19]. Our results are at variance with those
from Kraft et al. [18], who found no evidence for an effect of
the 93C>T polymorphism on Lp(a) concentrations in Cau-
casians. This discrepancy may be due either to the ethnic
composition and homogeneity of the study populations, or
to a potential masking on the biological effect of the 93C>T
polymorphism, which may be in linkage disequilibrium with
a repeat-allele.
With regard to the LPA 121G>A polymorphism, we found
no evidence of its role in modulating Lp(a) concentrations.
Our finding is in agreement with those from Zidkova et al.
[20], who reported a not significant influence of this polymor-
phism on Lp(a) concentrations. Thus, one can hypothesize
that this polymorphism does not have a functional role in
influencing the promoter activity, possibly representing only
a marker for another polymorphism that could affect gene
regulation.
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Limitations can be identified in this study: first of all,
our food-frequency questionnaire has been validated only to
assess food groups and not micro- and some specific types of
macronutrients, thereby not being able to establish the type
and quality of fatty acid intake consumed by our study pop-
ulation. Thus, the statistical value for the analyses of these
parameters could be strongly affected by such an insufficient
experimental accuracy. In addition, only two polymorphisms
of the several known genetic determinants contributing to
the great interindividual variability of Lp(a) concentrations,
were investigated. On the other hand, the two polymorphisms
studied in our study are of relevance since they are localized
in the promoter region of the gene, so contributing to the
variations of its transcription activity. Finally, because of the
observational design this study is unable to determine if nutri-
tional and genetic determinants as well as their interaction are
causally related to Lp(a) concentrations. A prospective study
would be the best way to confirm this finding.
However, several strengths are present: the high num-
ber of subjects analysed for nutritional, genetic determinants
of Lp(a) and circulating concentrations of Lp(a) as well as
the type of the study population investigated (i.e. healthy
middle-aged population). In addition, data of our study were
adjusted for several confounders which included, other than
age, dietary and lifestyle habits, also inflammatory markers
and menopause which are known to influence Lp(a) concen-
trations.
In conclusion, our findings, which demonstrated a role for
LPA 93C>T polymorphism in modulating Lp(a) phenotype
among a middle-aged healthy Caucasian population, on one
hand support the observation that variations of Lp(a) con-
centrations are under genetic control, whereas on the other
hand speculate on the gene–environment interaction in con-
trolling such atherosclerotic marker. At present, Lp(a) is not a
cardiovascular risk factor and there are no guidelines recom-
mending intervention to lower its circulating concentrations.
However, there is some consensus to indicate that Lp(a)
lowering might be beneficial in atherosclerotic patients as
a whole, and in some specific subgroups of patients [9]. Our
study, performed in a healthy population with normal Lp(a)
values does not give indications for lowering Lp(a) concentra-
tions below the threshold risk for atherosclerotic disease, but
only provides evidence for the possible modulation of Lp(a)
concentrations among a general population. On the other
hand, the possibility of modulating Lp(a) concentrations by
dietary means is intriguing since no effective measures for
lowering Lp(a) concentrations are, to date, available. Future
studies tailored on vascular patients with abnormal Lp(a)
concentrations will need to validate these results.
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